Free Trial

MEI Pharma (MEIP) Competitors

MEI Pharma logo
$2.15 0.00 (0.00%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$2.17 +0.02 (+0.93%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MEIP vs. DTIL, IKNA, KPTI, RENB, ARTV, OTLK, VNRX, PEPG, ATNM, and STTK

Should you be buying MEI Pharma stock or one of its competitors? The main competitors of MEI Pharma include Precision BioSciences (DTIL), Ikena Oncology (IKNA), Karyopharm Therapeutics (KPTI), Renovaro (RENB), Artiva Biotherapeutics (ARTV), Outlook Therapeutics (OTLK), VolitionRx (VNRX), PepGen (PEPG), Actinium Pharmaceuticals (ATNM), and Shattuck Labs (STTK). These companies are all part of the "pharmaceutical products" industry.

MEI Pharma vs.

Precision BioSciences (NASDAQ:DTIL) and MEI Pharma (NASDAQ:MEIP) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, community ranking, institutional ownership, analyst recommendations, profitability and media sentiment.

38.0% of Precision BioSciences shares are held by institutional investors. Comparatively, 52.4% of MEI Pharma shares are held by institutional investors. 4.5% of Precision BioSciences shares are held by company insiders. Comparatively, 3.1% of MEI Pharma shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Precision BioSciences has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500. Comparatively, MEI Pharma has a beta of 0.21, indicating that its stock price is 79% less volatile than the S&P 500.

In the previous week, Precision BioSciences had 2 more articles in the media than MEI Pharma. MarketBeat recorded 2 mentions for Precision BioSciences and 0 mentions for MEI Pharma. MEI Pharma's average media sentiment score of 0.00 beat Precision BioSciences' score of -0.31 indicating that MEI Pharma is being referred to more favorably in the news media.

Company Overall Sentiment
Precision BioSciences Neutral
MEI Pharma Neutral

Precision BioSciences has a net margin of 11.48% compared to MEI Pharma's net margin of 0.00%. Precision BioSciences' return on equity of -23.69% beat MEI Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Precision BioSciences11.48% -23.69% -6.98%
MEI Pharma N/A -84.92%-67.53%

MEI Pharma has lower revenue, but higher earnings than Precision BioSciences. Precision BioSciences is trading at a lower price-to-earnings ratio than MEI Pharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precision BioSciences$68.70M0.71-$61.32M-$2.01-2.31
MEI Pharma$65.30M0.22$17.78M-$4.75-0.45

Precision BioSciences presently has a consensus target price of $47.00, indicating a potential upside of 910.75%. Given Precision BioSciences' stronger consensus rating and higher possible upside, equities analysts plainly believe Precision BioSciences is more favorable than MEI Pharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision BioSciences
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
MEI Pharma
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

MEI Pharma received 327 more outperform votes than Precision BioSciences when rated by MarketBeat users. However, 69.06% of users gave Precision BioSciences an outperform vote while only 63.32% of users gave MEI Pharma an outperform vote.

CompanyUnderperformOutperform
Precision BioSciencesOutperform Votes
96
69.06%
Underperform Votes
43
30.94%
MEI PharmaOutperform Votes
423
63.32%
Underperform Votes
245
36.68%

Summary

Precision BioSciences beats MEI Pharma on 14 of the 18 factors compared between the two stocks.

Get MEI Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for MEIP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MEIP vs. The Competition

MetricMEI PharmaPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$14.32M$6.53B$5.38B$8.39B
Dividend YieldN/A2.64%5.21%4.10%
P/E Ratio-0.388.9226.7619.71
Price / Sales0.22252.24389.94117.54
Price / Cash0.4465.8538.2534.62
Price / Book0.656.466.804.50
Net Income$17.78M$143.98M$3.23B$248.18M
7 Day Performance0.94%2.03%1.52%0.23%
1 Month Performance6.44%4.11%10.04%12.39%
1 Year Performance-32.60%-2.87%16.73%7.07%

MEI Pharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MEIP
MEI Pharma
2.1973 of 5 stars
$2.15
flat
N/A-31.1%$14.32M$65.30M-0.38100Gap Down
DTIL
Precision BioSciences
3.4772 of 5 stars
$5.22
+1.8%
$47.00
+800.4%
-64.4%$55.07M$68.70M87.01200Earnings Report
Analyst Forecast
IKNA
Ikena Oncology
2.8372 of 5 stars
$1.14
+0.9%
$3.00
+163.2%
-16.7%$55.01M$659,000.00-0.9370Positive News
Gap Up
KPTI
Karyopharm Therapeutics
3.8339 of 5 stars
$6.15
+2.3%
$57.50
+835.0%
-72.0%$52.71M$145.24M-6.03380Gap Down
RENB
Renovaro
0.8116 of 5 stars
$0.32
+2.4%
N/A-69.9%$51.30MN/A-0.3520
ARTV
Artiva Biotherapeutics
1.7053 of 5 stars
$2.10
+1.0%
$20.40
+871.4%
N/A$51.16M$251,000.000.0081
OTLK
Outlook Therapeutics
1.9942 of 5 stars
$1.59
+3.9%
$10.20
+541.5%
-79.3%$50.91MN/A-0.2120Earnings Report
VNRX
VolitionRx
1.8945 of 5 stars
$0.49
-1.0%
$3.33
+573.7%
-29.0%$49.86M$1.23M-1.3780Gap Up
PEPG
PepGen
3.1313 of 5 stars
$1.51
+0.7%
$9.67
+540.2%
-89.6%$49.41MN/A-0.5130Gap Up
ATNM
Actinium Pharmaceuticals
1.2083 of 5 stars
$1.55
+4.7%
$4.00
+158.1%
N/A$48.35M$81,000.00-1.1230Trending News
STTK
Shattuck Labs
2.5735 of 5 stars
$0.99
+4.4%
$7.50
+657.6%
-86.1%$47.42M$4.61M-0.65100

Related Companies and Tools


This page (NASDAQ:MEIP) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners